Dorman Products, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Dorman Products, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	860	903	974	991	1,093	1,345	1,734	1,930	2,009	2,130
Cost of revenue	522	545	600	652	710	882	1,169	1,244	1,203	1,233
Gross profit	338	359	373	340	383	463	564	685	806	898
Selling, general and administrative	169	182	202	234	250	291	393	471	513	541
Operating income	169	176	171	106	133	172	171	215	293	300
Interest expense	0.24			0.23	0.6	2.16	15.6	48.1	39.7	28.6
Other non-operating income	-0.24	0.35	-0.01	0.21	2.96	0.38	0.74	1.8	3.07	4.47
Pre-tax income	168	177	171	106	136	170	156	169	256	275
Income tax	62.3	70	37.5	22	28.9	38.2	34.7	39.2	66.2	71.3
Net income	106	107	134	83.8	107	132	122	129	190	204
EBITDA	188	198	200	132	166	207	216	269	350	355
EPS, basic	3.07	3.14	4.04	2.57	3.31	4.13	3.87	4.11	6.17	6.69
EPS, diluted	3.07	3.13	4.02	2.56	3.30	4.12	3.85	4.10	6.14	6.64
Shares, basic (weighted)	34.5	34	33.1	32.6	32.3	31.8	31.4	31.5	30.8	30.5
Shares, diluted (weighted)	34.6	34.1	33.2	32.7	32.4	32	31.5	31.5	31	30.8

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	149	71.7	43.5	68.4	156	58.8	46	36.8	57.1	49.4
Receivables	231	242	401	392	461	473	427	527	574	479
Inventory	169	212	271	281	299	532	756	637	708	959
Other current assets	3.12	7.13	5.65	13.6	7.76	13	39.8	32.7	30.9	33.8
Total current assets	552	533	720	755	923	1,077	1,269	1,234	1,370	1,522
Property, plant and equipment	88.4	92.7	98.6	102	91	115	148	160	164	169
Lease right-of-use assets				32.2	39	59	110	103	118	113
Goodwill	28.1	66	72.6	74.5	91.1	197	443	444	443	387
Intangible assets	1.64	22.2	25.2	21.3	25.2	179	322	302	278	257
Other non-current assets	29.5	44.3	55.2	52.3	39	46.5	48.8	49.7	44.9	45.6
Total assets	712	766	978	1,041	1,221	1,673	2,342	2,292	2,425	2,493
Accounts payable	72.6	80.2	109	90.4	118	177	180	177	232	185
Accrued liabilities	19.3	18.4	11.6	14.4	19.7	26.6	19.5	24	44	30.8
Short-term debt						0	12.5	15.6	28.1	37.5
Total current liabilities	104	111	232	221	323	665	678	547	564	493
Long-term debt						0	482	467	440	402
Lease liabilities				29.7	37.1	52.4	98.2	91.3	105	96.6
Other non-current liabilities	6.3	13.7	13.6	13.3	3.56	4.92	28.3	9.63	18.9	20.2
Total liabilities	110	131	250	267	367	740	1,299	1,124	1,131	1,016
Total debt						0	495	483	469	441
Paid-in capital	44.2	44.8	47.9	52.6	64.1	77.5	88.8	101	119	137
Retained earnings	557	590	679	721	789	856	957	1,069	1,181	1,344
Other comprehensive income						-1.44	-3.3	-2.59	-6.78	-4.52
Shareholders' equity	602	635	728	774	854	933	1,043	1,168	1,293	1,477
Total equity	602	635	728	774	854	933	1,043	1,168	1,293	1,477
Total liabilities and equity	712	766	978	1,041	1,221	1,673	2,342	2,292	2,425	2,493
Shares outstanding	34.5	33.6	33	32.6	32.2	31.6	31.4	31.3	30.6	30.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	106	107	134	83.8	107	132	122	129	190	204
Depreciation and amortization	18.9	22.2	28.4	25.9	32.3	35.2	44.7	54.7	56.7	55.7
Stock-based compensation	2.38	3.16	3.46	3.08	7.59	8.23	9.37	11.5	15	19.6
Deferred income tax	-4.89	4.68	-0.06	1.06	-9.6	-12	-5.88	-2.96	-10.8	6.15
Change in receivables	-27.8	-5.71	-61.4	8.81	-67.4	10.9	48.5	-104	-47.2	94.4
Change in inventory	24.9	-25.1	-46.8	-11	-12.3	-154	-134	119	-72.1	-250
Cash from operations	122	94.2	78.1	95.3	152	100	41.7	209	231	114
Capital expenditures	-20.1	-24.5	-26.1	-29.6	-15.5	-19.8	-37.9	-44	-39.4	-38
Acquisitions		-60	-28		-14.8	-345	-489	0.07	0.1	0
Purchases of investments	-6.2	-10	-5
Cash from investing	-26.3	-94.4	-59.1	-29.6	-30.3	-365	-527	-43.9	-39.3	-38
Debt issued					0	0	500	0	0
Debt repaid					0	0	-3.13	-12.5	-15.6	-28.1
Stock issued		0.03	0.2	0.12	1.18	2.46	1.05	1.17	4.71	3.7
Cash from financing	-24.8	-77.3	-46.9	-40.9	-34.5	168	472	-174	-171	-83.7
Net change in cash	70.5	-77.4	-28.2	24.9	87.2	-96.8	-12.7	-9.22	20.3	-7.7
Free cash flow	101	69.8	52	65.7	137	80.5	3.81	165	192	75.7
Interest paid	0.27	0.29	0.25	0.34	0.75	1.78	11.6	49.5	38.7	27.4
Income taxes paid	62.3	74.6	30.5	28.9	28.3	46.2	62.9	35.5	56.7	68.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $124.02 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	42.3%	Gross profit / revenue.
Operating margin	14.5%	Operating income / revenue.
EBITDA margin	17.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	13.7%	Pre-tax income / revenue.
Net margin	10.2%	Net income / revenue.
FCF margin	9.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	11.6%	Cash from operations / revenue.
Effective tax rate	26.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	14.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	8.8%	Net income / average total assets.
Return on invested capital (ROIC)	12.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	25.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.7%	Capital expenditures / revenue.
D&A / revenue	2.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	6.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	7.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	14.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	11.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	16.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	18.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	2.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	20.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	17.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	1.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	18.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	16.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	7.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	18.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	13.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	8.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	19.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	15.0%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-50.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	39.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-5.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-60.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	170.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-11.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	14.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	12.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	11.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	2.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	2.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	15.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.60x	Current assets / current liabilities.
Quick ratio	1.59x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.31x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.29x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	17.6%	Total debt / total assets.
Liabilities / assets	39.4%	Total liabilities / total assets.
Net debt	$308.5M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.84x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	11.9x	Operating income / interest expense.
Working capital	$1.12B	Current assets - current liabilities.
Goodwill and intangibles / assets	25.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	$881.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.86x	Revenue / average total assets.
Fixed asset turnover	12.9x	Revenue / average property, plant and equipment.
Inventory turnover	1.54x	Cost of revenue / average inventory.
Days inventory	237 days	365 x average inventory / cost of revenue.
Receivables turnover	3.89x	Revenue / average receivables.
Days sales outstanding	94 days	365 x average receivables / revenue.
Days payables	48 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	283 days	Days inventory + days sales outstanding - days payables.
FCF conversion	97.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	14.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$7.31	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$71.85	Revenue / diluted weighted shares.
FCF per share	$7.14	Free cash flow / diluted weighted shares.
Operating cash flow per share	$8.34	Cash from operations / diluted weighted shares.
Book value per share	$51.07	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$29.71	Tangible book value / shares outstanding.
Cash per share	$4.45	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$3.68B	Share price x shares outstanding.
Enterprise value	$3.99B	Market cap + total debt - cash - short-term investments.
P/E	16.8x	Market cap / net income. Only when net income is positive.
P/S	1.71x	Market cap / revenue.
P/B	2.43x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	4.18x	Market cap / tangible book value, when positive.
P/FCF	17.2x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	14.7x	Market cap / cash from operations, when positive.
EV/Sales	1.85x	Enterprise value / revenue.
EV/EBIT	12.8x	Enterprise value / operating income, when both are positive.
EV/EBITDA	10.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	18.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	5.8%	Free cash flow / market cap.
Earnings yield	6.0%	Net income / market cap (the inverse of P/E).
PEG	0.84x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Dorman Products, Inc.'s revenue in fiscal 2025?

Dorman Products, Inc. reported revenue of $2.13B for fiscal 2025, 6% higher than the year before.

Was Dorman Products, Inc. profitable in fiscal 2025?

Yes. Net income was $204.2M, a net margin of 9.6%.

How much free cash flow did Dorman Products, Inc. generate in fiscal 2025?

Cash from operations of $113.6M minus capital expenditures of $38.0M left free cash flow of $75.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Dorman Products, Inc.